Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats

Life Sciences

Volumn 63, Issue 7, 1998, Pages 511-521

  Morishima, Itsuro ^a   Matsui, Hideo ^a   Mukawa, Hiroaki ^a   Hayashi, Kazunori ^a   Toki, Yukio ^a   Okumura, Kenji ^a   Ito, Takayuki ^a   Hayakawa, Tetsuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adriamycin induced cardiomyopathy; Antioxidant; Lipid peroxidation; Melatonin

Indexed keywords

ANTIOXIDANT; DOXORUBICIN; MELATONIN; PINEAL BODY HORMONE; PROBUCOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ELECTRON MICROSCOPY; HEART PERFORMANCE; HEART PROTECTION; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MORTALITY; NONHUMAN; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; DOXORUBICIN; HEART; HEART FAILURE, CONGESTIVE; LIPID PEROXIDES; MALE; MELATONIN; PROBUCOL; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0032504097     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00302-6     Document Type: Article

References (41)

1. 1. R.C. YOUNG, R.F. OZOLS and C.E. MYERS, New Engl J Med 305 139-153 (1981).
2. 2. D.J. BOOSER and G.N. HORTOBAGYI, Drugs 47 223-258 (1994).
3. 3. E.A. LEFRAK, J. PITHA, S. ROSENHEIM and J.A. GOTTLIEB, Cancer 32 302-314 (1973).
4. 4. L.J. STEINHERZ, P.G. STEINHERZ, C.T.C. TAN, G. HELLER and M.L. MURPHY, JAMA 266 1672-1677 (1991).
5. 5. P.K. SINGAL, C.M.R. DEALLY and L.E. WEINBERG, J Mol Cell Cardiol 19 817-828 (1987).
6. 6. R.D. OLSON and P.S. MUSHLIN, FASEB J 4 3076-3086 (1990).
7. 7. N. ILISKOVIC and P.K. SINGAL, Am J Pathol 150 727-734 (1997).
8. 8. R. JEYASEELAN, C. POIZAT, H.Y. WU and L. KEDES, J Biol Chem 272 5828-5832 (1997).
9. 9. C.E. MYERS, W.P. MCGUIRE, R.H. LISS, I. IFRIM, K. GROTZINGER and R.C. YOUNG, Science 197 165-167 (1977).
10. 10. E.G. MIMNAUGH, M.A. TRUSH, M. BHATNAGAR and T.E. GRAM, Biochem Pharmacol 34 847-856 (1985).
11. 11. N.A. SARVAZYAN, A. ASKARI and W.H. HUANG, Life Sci 57 1003-1010 (1995).
12. 12. P.K. SINGAL, N. SIVESKI-ILISKOVIC, M. HILL, T.P. THOMAS and T. LI, J Mol Cell Cardiol 27 1055-1063 (1995).
13. 13. J.H. DOROSHOW, G.Y. LOCKER, I. IFRIM and C.E. MYERS, J Clin Invest 68 1053-1064 (1981).
14. 14. E.H. HERMAN and V.J. FERRANS, Cancer Res 41 3436-3440 (1981).
15. 15. D.D. VON HOFF, D. HOWSER, B.J. LEWIS, J. HOLCENBERG, R.B. WEISS and R.C. YOUNG, Cancer Treat Rep 65 249-252 (1981).
16. 16. D.X. TAN, L.D. CHEN, B. POEGGELER, L.C. MANCHESTER and R.J. REITER, Endocr J 1 57-60 (1993).
17. 17. C. PIERI, M. MARRA, F. MORONI, R. RECCHIONI and F. MARCHESELLI, Life Sci 55 PL 271-276 (1994).
18. 18. E. GILAD, S. CUZZOCREA, B. ZINGARELLI, A.L. SALZMAN and C. SZABÓ, Life Sci 60 PL 169-174 (1997).
19. 19. S. CUZZOCREA, B. ZINGARELLI, E. GILAD, P. HAKE, A.L. SALZMAN and C. SZABÓ, J Pineal Res 23 106-116 (1997).
20. 20. R.J. REITER, L. TANG, J.J. GARCIA and A. MUÑOZ-HOYOS, Life Sci 60 2255-2271 (1997).
21. 21. C.S. SHIDA, A.M.L. CASTRUCCI and M.T. LAMY-FREUND, J Pineal Res 16 198-201 (1994).
22. 22. D. MELCHIORRI, R.J. REITER, A.M. ATTIA, M. HARA, A. BURGOS and G. NISTICÓ, Life Sci 56 83-89 (1995).
23. 23. E. SEWERYNEK, D. MELCHIORRI, R.J. REITER, G.G. ORTIZ and A. LEWINSKI, Eur J Pharmacol 293 327-334 (1995).
24. 24. Z.R. LI, R.J. REITER, O. FUJIMORI, C.S. OH and Y.P. DUAN, J Pineal Res 22 117-123 (1997).
25. 25. S. BERTUGLIA, P.L. MARCHIAFAVA and A. COLANTUONI, Cardiovasc Res 31 947-952 (1996).
26. 26. N. SIVESKI-ILISKOVIC, M. HILL, D.A. CHOW and P.K. SINGAL, Circulation 91 10-15 (1995).
27. 27. G. DE SIMONE, D.C. WALLERSON, M. VOLPE and R.B. DEVEREUX, Am J Hypertens 3 688-696 (1990).
28. 28. D.J. SAHN, A. DE MARIA, J. KISSLO and A. WEYMAN, Circulation 58 1072-1083 (1978).
29. 29. H. MUKAWA, Y. TOKI, A. SHIMAUCHI, H. MATSUI, I. MORISHIMA, K. OKUMURA, T. ITO and T. HAYAKAWA, J Hypertens 15 1027-1032 (1997).
30. 30. J.A. BUEGE and S.D. AUST, Meth Enzymol 52 302-310 (1978).
31. 31. G. AMBROSIO, J.T. FLAHERTY, C. DUILIO, I. TRITTO, G. SANTORO, P.P. ELIA, M. CONDORELLI and M. CHIARIELLO, J Clin Invest 87 2056-2066 (1991).
32. 32. K. YAGI, Biochem Med 15 212-216 (1976).
33. 33. M.P. PYE, M. BLACK and S.M. COBBE, Caidiovasc Res 31 873-881 (1996).
34. 34. N. SIVESKI-ILISKOVIC, N. KAUL and P.K. SINGAL, Circulation 89 2829-2835 (1994).
35. 35. B.P. YU, Physiol Rev 74 139-162 (1994).
36. 36. J. VÁSQUEZ-VIVAR, P. MARTASEK, N. HOGG, B.S.S. MASTERS, K.A. PRITCHARD Jr. and B. KALYANARAMAN, Biochemistry 36 11293-11297 (1997).
37. 37. L.R. BARLOW-WALDEN, R.J. REITER, M. ABE, M. PABLOS, A. MENENDEZ-PELAEZ, L.D. CHEN and B. POEGGELER, Neurochem Int 26 497-502 (1995).
38. 38. B. POEGGELER, R.J. REITER, R. HARDELAND, D.X. TAN and L.R. BARLOW-WALDEN, Redox Report 2 179-184 (1996).
39. 39. P. MONTILLA, I. TÚNEZ, M.C. MUÑOZ, A. LÓPEZ and J.V. SORIA, Nephron 76 345-350 (1997).
40. 40. P. ZIMETBAUM, H. EDER and W, FRISHMAN, J Clin Phamacol 30 3-9 (1990).
41. 41. A. BRZEZINSKI, New Engl J Med 336 186-195 (1997).